Form 4: Akero Therapeutics Executive Sells Shares to Cover Tax Obligations

Patrick Lamy, Senior VP of Commercial Strategy at Akero Therapeutics, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Patrick Lamy, Senior VP of Commercial Strategy at Akero Therapeutics, sold 569 shares of common stock on June 11, 2024, at a price of $22.641 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units, in accordance with the company's 'sell-to-cover' policy.
• Following the transaction, Lamy beneficially owns 18,562 shares of Akero Therapeutics common stock, which includes 561 shares acquired under the Employee Stock Purchase Plan on December 29, 2023.
• The shares were sold in multiple transactions at prices ranging from $22.640 to $22.760.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing relates to a routine transaction for tax purposes and doesn't indicate any fundamental change in the company's prospects or the executive's confidence.

Industry Context

Executive stock sales are a common occurrence and are often related to personal financial planning or tax obligations. The 'sell-to-cover' policy is a standard practice to manage tax liabilities associated with equity compensation.

Key Dates